Ceva Animal Health

What Ceva Animal Health does

Ceva Animal Health is a global veterinary pharmaceutical company that develops, manufactures, and markets medicines, vaccines, and animal health products for companion animals (dogs, cats, horses) and production animals (cattle, sheep, pigs, poultry). Its portfolio is anchored by pheromone-based behavioral products (ADAPTIL for dogs and FELIWAY for cats), dermatology lines (DOUXO S3), parasiticides (Vectra 3D), and a vaccines and biologics franchise that includes government-selected vaccines for avian influenza containment. The company also markets nutritional supplements (Diarsanyl, Rehydion) and complementary non-pharmaceutical behavioral products such as the ThunderShirt anxiety vest.

Ceva's technology base spans animal health pharmaceuticals, biologics, vaccines, and pheromone-based therapeutics, with 12 R&D centers and 25 production facilities worldwide (including 4 main facilities and 20+ regional biological production facilities). A January 2025 partnership with Touchlight extends the technology footprint into synthetic dbDNA genetic-medicine vaccines, structured with upfront, milestone, and royalty economics. Ceva employs more than 7,000 people and operates in 45 countries with active projects in more than 110 countries, with wholly-owned operating subsidiaries including Biomune (US), Ceva Phylaxia (Hungary), CEVA SOGEVAL (France), and Brazilian manufacturing entities (Ceva Saúde Animal, Hertape, Inova Biotecnologia).

The business model combines three distribution channels: direct sales to veterinary professionals for prescription products, pet retail and veterinary pharmacy channels for over-the-counter companion animal products, and agricultural distributors and livestock cooperatives for livestock and poultry vaccines. Revenue streams include one-time product sales across pharmaceuticals, vaccines and biologics, pheromone products, and parasiticides, plus licensing and royalty streams from technology partnerships such as Touchlight. Ownership is private and institutional, with Temasek-led existing investors, the Bettencourt-Meyers family, and new 2025 entrants Mérieux Institute and ARCHIMED; the company raised €5.5 billion in equity in December 2025 at a €9.2 billion post-money valuation, with the CEO indicating a potential IPO within four to five years.

Name

Ceva Animal Health

Legal name

Ceva Animal Health AB

Website

https://ceva.nu

Company type

Private

Operating status

Operating

Short description

Ceva Animal Health is a global veterinary pharmaceutical company developing and marketing medicines, vaccines, pheromone therapeutics, parasiticides, and dermatology products for companion animals, livestock, and poultry across 45+ countries, with 7,000+ employees, 12 R&D centers, and 25 production facilities.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Veterinary Services (541940)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Livestock & Farm Animal Veterinary Services (AFAEANAB), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Companion animal care
• Livestock vaccines
• Pet behavior solutions

Headquarters

HQ city

Lund

HQ country

Sweden

HQ region

Europe

Offices13 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Animal Health Products: Sale of veterinary pharmaceuticals, vaccines, and biologics for companion animals and livestock
2. Vaccines and Biologics: Production and sale of vaccines for poultry, livestock, and companion animals including government-selected vaccines for disease control
3. Pheromone Products: Sale of pheromone-based products including ADAPTIL and FELIWAY for behavioral management in dogs and cats
4. Parasiticides: Sale of anti-parasitic products such as Vectra 3D for fleas, ticks, and flying insects
5. Licensing and Royalties: Development milestones and royalties from partnership products commercialized through collaboration agreements

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Ceva Animal Health is a global veterinary pharmaceutical company that develops, manufactures, and markets animal health products for both companion animals (dogs, cats) and farm animals (cattle, swine, poultry). The portfolio spans prescription pharmaceuticals, vaccines, parasiticides, dermatology products, pheromone-based behavior solutions, nutritional supplements, and medical devices, sold through veterinary channels, pet retail, and agricultural distribution networks worldwide.

Product overview

Ceva Animal Health is a global veterinary pharmaceutical company specializing in research, production, and marketing of medicines and vaccines for companion animals, cattle, sheep, pigs, and poultry. The company's product portfolio is organized around three main categories: (1) Pheromone-based behavioral products including ADAPTIL (for dogs) and FELIWAY (for cats) product lines offering collars, diffusers, sprays, and treats to manage stress and anxiety; (2) Dermatological skincare products under the DOUXO S3 brand including shampoos, mousses, and ear cleansers for dogs, cats, and horses; and (3) Parasiticides such as Vectra 3D spot-on solution. Additionally, Ceva offers nutritional supplements including Diarsanyl for gastrointestinal support and Rehydion electrolyte gel for hydration. Ceva operates across 45 countries with 12 R&D centers and 25 production facilities worldwide, employing more than 7,000 people.

Differentiator

Problem solved

Functional benefit

Brands

• FELIWAY: Pheromone products for cats
• ADAPTIL
• DOUXO S3
• Vectra 3D
• Amodeus
• ThunderShirt

Products and services

• ADAPTIL Range of dog-appeasing pheromone-based products (collars, diffusers, sprays, soft chews) designed to reduce stress and anxiety-related behaviors in puppies and dogs; targeted at dog owners and recommended by veterinarians.
• FELIWAY Synthetic cat facial pheromone-based product range (diffusers, sprays, calming snacks) intended to reduce unwanted behaviors such as scratching, urine marking, and tension in cats; sold to cat owners through veterinary and pet retail channels.
• DOUXO S3 Veterinary dermatology skincare line for dogs and cats covering sensitive, irritated, or unbalanced skin and ears, available as shampoos, mousses, and auricular (ear) lotions; prescribed or recommended by veterinarians.
• Vectra 3D Topical spot-on parasiticide product for dogs providing protection against fleas, ticks, mosquitoes, and biting flies; sold through veterinary channels for parasite control.
• Rehydion Oral rehydration gel formulated with electrolytes and energy sources for calves and horses experiencing dehydration, stress, or digestive upset; used by livestock owners and veterinarians.
• Diarsanyl Oral nutritional supplement (paste) containing electrolytes, energy sources, and protective ingredients for acute intestinal absorption disorders in calves, dogs, and cats; used under veterinary guidance.
• ThunderShirt Non-pharmaceutical calming garment/vest for dogs that applies gentle, constant pressure to reduce anxiety during thunderstorms, travel, and other stressful events; sold through pet retail and online channels to dog owners.

Quantifiable outcome

• Selected by French government for bird flu vaccine supply

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• TouchlightcoreTechnology or Integration · 20 January 2025Partnership to utilize Touchlight's dbDNA technology for developing new animal health therapeutics. Agreement includes upfront payments, development milestones, and royalties on commercialized products. Combines Ceva's vaccine expertise with Touchlight's synthetic DNA capabilities for genetic medicine vaccines.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IDEXX Laboratories: IDEXX is a leader in veterinary diagnostics and software with an adjacent companion animal therapeutic presence. It operates in the same veterinary customer channel as Ceva but with a diagnostic rather than pharmaceutical focus.
• Merck Animal Health: Merck Animal Health is the animal health division of Merck & Co., offering vaccines, anti-infectives, and parasiticides across companion and production animals. Larger and more diversified than Ceva but competes across multiple of Ceva's product lines.

Direct peers

• Elanco Animal Health: Elanco is a leading global animal health company with strong positions in companion animal parasiticides and livestock health (post-Bayer Animal Health acquisition). It is one of Ceva's named top-6 parasiticide competitors.
• Vetoquinol: Vetoquinol is a French independent animal health company specializing in companion animal pharmaceuticals, parasiticides, and dermatology — overlapping with Ceva's DOUXO and Vectra 3D franchises.
• Virbac: Virbac is a France-based global animal health company focused on companion animal vaccines, parasiticides, and dermatology. It is one of Ceva's named top-6 parasiticide competitors and a close geographic peer.
• Phibro Animal Health: Phibro Animal Health is a global animal health and nutrition company focused on livestock vaccines, parasiticides, and feed additives. It is comparable to Ceva's livestock and poultry vaccine business.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health division is a top global player in veterinary vaccines, parasiticides, and therapeutics for companion and production animals. It competes head-to-head with Ceva in vaccines and parasiticides.
• Zoetis: Zoetis is the largest global pure-play animal health company, offering vaccines, parasiticides, dermatology, and diagnostics across companion animals and livestock. It is Ceva's most direct competitor across nearly every category in which Ceva operates.
• Dechra Pharmaceuticals: Dechra (now part of Elanco) was a UK-based veterinary pharmaceuticals company specializing in companion animal therapeutics, dermatology, and endocrinology — directly comparable to Ceva's DOUXO S3 dermatology line.

Emerging players

• Heska (Mars Petcare): Heska (acquired by Mars Petcare in 2023) develops and markets veterinary diagnostics and specialty therapeutics, particularly for companion animals. Smaller scale than Ceva and more focused, but operates in the same veterinary channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ceva Animal Health